Vaccine-Derived Polioviruses, Central African Republic, 2019 - Institut Pasteur Access content directly
Journal Articles Emerging Infectious Diseases Year : 2021

Vaccine-Derived Polioviruses, Central African Republic, 2019


Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations (<20) in the viral capsid protein 1-encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably <3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children.
Fichier principal
Vignette du fichier
20-3173.pdf (1.7 Mo) Télécharger le fichier
20-3173-app1.pdf (467.75 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

pasteur-03122581 , version 1 (27-01-2021)





Marie-Line Joffret, Joël Wilfried Doté, Nicksy Gumede, Marco Vignuzzi, Maël Bessaud, et al.. Vaccine-Derived Polioviruses, Central African Republic, 2019. Emerging Infectious Diseases, 2021, 27 (2), pp.620-623. ⟨10.3201/eid2702.203173⟩. ⟨pasteur-03122581⟩
35 View
59 Download



Gmail Facebook X LinkedIn More